ATTO: Attovia Therapeutics, Inc.
Performance
ATTO -27.12%
Watchlist
Select an item
Summary
ATTO at a glance
ATTO returned -27.12% since Aug 5, 2026. Its worst drop since then was -46.26%, smaller than 28% of stocks on Redstone, and its Sharpe ratio of -1.24 beats 2% of stocks on Redstone. It hasn't paid a dividend since it listed.
Current Drawdown
-37.53%
Rolling Volatility
63.55%
Actions
Metrics
Risk Indicators*
Alpha-79.52%
Beta1.41x
Sharpe-1.24
Sortino-1.69
Omega0.82
Calmar-0.59
Martin-3.32
Profile
About ATTO
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $729M
- Listed
- Aug 2026
- Headquarters
- San Carlos, CA
- Website
- attovia.com
Comparisons